In a previous study we found that 50% ethanol extracts of immature fruits of Citrus unshiu (satsuma mandarin) have anti-allergic effects against the Type I, II and IV allergic reactions. However, many adverse interactions between citrus fruit, especially grapefruit juice, and drugs have been reported due to the inhibition of cytochrome P450 (CYP) activities. The purpose of this study was to examine the competitive inhibitory effects of extracts from immature citrus fruit on CYP activity. Extracts were prepared from 12 citrus species or cultivars, and were tested against three kinds of major CYPs, CYP2C9, CYP2D6 and CYP3A4, in human liver microsomes. We also estimated the amounts of flavonoids (narirutin, hesperidin, naringin and neohesperidin) and furanocoumarins (bergapten, 6,7-dihydroxybergamottin and bergamottin) in each extract using HPLC. Citrus paradisi (grapefruit) showed the greatest inhibition of CYP activities, while Citrus unshiu which has an antiallergic effect, showed relatively weak inhibitory effects. Extracts having relatively strong inhibitory effects for CYP3A4 tended to contain higher amounts of naringin, bergamottin and 6,7-dihydroxybergamottin. These results, providing comparative information on the inhibitory effects of citrus extracts on CYP isoforms, suggest that citrus extracts containing high levels of narirutin and hesperidin and lower levels of furanocoumarins such as C. unshiu are favorable as antiallergic functional ingredients.
Many flavonoids and furanocoumarins are present in fruits, vegetables and beverages derived from plants. Flavonoids have been described as health-promoting and disease-preventing dietary supplements. 1) Recently, dietary supplements and herbal products containing flavonoids have become very popular due to increased public interest in healthpromotion and disease-prevention. Flavonoid-or furanocoumarin-drug interactions have been reported in clinical studies. For example, flavonoids and furanocoumarins in grapefruit juice affect the oral bioavailability of a variety of drugs, including the dihydropyridine calcium channel blockers, cyclosporin A, midazolam, triazolam, terfenadine, saquinavir and ethynylestradiol. [2] [3] [4] Many instances of flavonoid-or furanocoumarin-drug interactions have also been reported from rodent studies. [1] [2] [3] These interactions could mainly take place in small intestine. On average, CYP3A and CYP2C9 represent the major pieces of the intestinal CYP, accounting for 80% and 15%, respectively, of total immunoquantified CYP. CYP2D6, 2C19 and 2J2 represent a few percent of intestinal CYP. 5) Citrus fruit extracts contain flavonoids and furanocoumarins. Our previous investigation demonstrated that immature citrus fruit extracts contained relatively high amounts of flavonoids, such as hesperidin, narirutin and naringin. 6) Hesperidin has an antiallergic effect by inhibiting histamine release from mast cells. On the other hand, it is reported that furanocoumarins such as bergamottin, 6Ј,7Ј-dihydroxybergamottin (6Ј,7Ј-DHB), bergaptol and bergapten are involved in CYP3A4 inhibition. 7, 8) Furanocoumarins also inhibit the activities of other CYP isoforms such as CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP2E1. 9, 10) Inhibition of CYP enzymes, including CYP1A1, CYP1A2, CYP2E1 and CYP3A4 by competitive binding and/or mechanism-based inhibition also occurs. 4, 11) However, there is little comprehensive information about the inhibitory effects of citrus extracts on CYP activities. We investigated the effects of extracts from immature fruits of 12 citrus species or cultivars on the activities of CYP3A4, 2D6 and 2C9 existing in small intestine because these CYP isoforms exist relatively abundantly in small intestine. We used the extracts rather than juices of the immature fruits to test the possibility for medicinal resources. The quantitative correlation of the flavonoids or furanocoumarins contents of the citrus extracts with their inhibitory effect on CYP3A4 activity was also examined. This study also indicated that the inhibitory effects of immature Citrus unshiu (satsuma mandarin) on CYP activities are relatively low among the 12 citrus extracts examined.
MATERIALS AND METHODS

Materials
Extracts from immature fruit of 12 Citrus species or cultivars were used; C. iyo, C. limon, C. naruto, C. sinensis var. brasiliensis, C. aurantiun var. daidai, C. sulcata, C. reticulata, C. grandis, C. paradisi, C. sinensis, C. natsudaidai and C. unshiu, which were harvested in August and provided by the Yuasa Experimental Farm of Kinki University. Mixed gender pooled 50 human liver microsomes were obtained from XenoTech (Lenexa, KS, U.S.A.). Midazolam injection (10 mg/2 ml, Dormicum ® ) was purchased from Astellas Pharma (Tokyo, Japan). 1Ј-Hydroxymidazolam, dextromethorphan and O-demethyldextromethorphan were obtained from Daiichi Pure Chemicals Co., Ltd. (Tokyo, Japan). b-NADP ϩ , glucose-6-phosphate, and glucose-6-phosphate dehydrogenase were purchased from Oriental Yeast Co. (Tokyo, Japan). All other chemicals were reagent grade products obtained commercially.
Preparation of Extracts of the Fruits
The extracts were prepared from the fruits according to a standard method. 6) In brief, the crushed drying fruits (300 g) were extracted once with 50% ethanol (3 l) under reflux for 2 h. The filtrates were concentrated under reduced pressure and lyophilized. In Table 1 , the yield (%) of extract for each fruit was shown. Citrus Extracts' Inhibition of CYP Isoforms Midazolam 1Ј-hydroxylation (MD1H) activity for CYP3A4 and dextromethorphan O-demethylation (DMOD) activity for CYP2D6 in the presence or absence of the citrus extracts were determined as follows. An incubation mixture (0.2 ml total volume) was prepared, containing 100 mM potassium phosphate buffer (pH 7.4), 20 ml of distilled water or citrus extract solution at final concentrations of 0.01 to 5 mg/ml, an NADPH generating system [1.3 mM b-NADP ϩ , 3.3 mM glucose-6-phosphate, 0.4 IU/ml glucose-6-phosphate dehydrogenase, and 3.3 mM MgCl 2 , 0.5 mg/ml human microsomes, and 10 mM midazolam (CYP3A4) or dextromethorphan (CYP2D6). The concentrations of each substrate used were around the expected K m values: 25 mM midazolam, 50 mM dextromethorphan.
12) The reaction was initiated by addition of the NADPH generating system after preincubation for 5 min at 37°C, and was carried out for 10 min at 37°C with constant shaking.
For the assay of MD1H activities, the reaction was terminated by the addition of 0.5 ml of 0.1 M Na 2 CO 3 and 0.1 ml of 3.0 mg/ml diazepam methanol solution as an internal standard. Then 5 ml ethyl acetate was added and the mixture shaken for 15 min. After centrifugation at 5000ϫg for 15 min, the organic layer was evaporated with a centrifugal evaporator (Tokyo Rikakikai Co., Ltd., Tokyo, Japan). The residues were dissolved with 100 ml of 20% of acetonitrile in 10 mM phosphate buffer (pH 7.4), and analyzed using highperformance liquid chromatography (HPLC) as described below. The HPLC system consisted of a model LC10A HPLC (Shimadzu, Kyoto, Japan). Chromatography was conducted in a 3.5 mm Symmetry C18 column (4.6ϫ150 mm, 5 mm) (Waters, Milford, MA, U.S.A.). The column temperature was set at 40°C, and a UV-detector was set at 254 nm. The mobile phase consisted of acetonitrile : methanol : 10 mM potassium phosphate buffer (pH 7.4) (7 : 5 : 12). Flow rate was maintained at 1 ml/min.
For the assay of DMOD activities, the reaction was terminated by the addition of 200 ml of acetonitrile. Each sample was then filtered through 0.45 mm filter after centrifugation at 5000ϫg for 10 min. The filtrates were analyzed using HPLC. The HPLC system consisted of a model LC10A HPLC equipped with a fluorescence detector (RF-10AXL, Shimadzu, Kyoto, Japan). Chromatography was conducted using a Inertsil ODS-2 column (4.6ϫ250 mm, 5 mm) (GL Sciences, Tokyo, Japan). The column temperature was set at 40°C, and the detector was set at 285 (excitation) and 310 nm (emission). The mobile phase consisted of acetonitrile: 10 mM citric acid buffer (pH 7.4) (35 : 65). Flow rate was maintained at 1 ml/min. CYP2C9 activity was determined using a P450-Glo TM CYP2C9 assay (Promega, Madison, WI, U.S.A.) according to the manufacturer's instructions (since the HPLC peak derived from citrus extracts interfered with the determination of the metabolite of the substrate on the chromatogram). In brief, the above mentioned incubation mixture was used and the reaction were performed in a 96-well plate [OptiPlate TM -96 (PerkinElmer, Waltham, MA, U.S.A.)] for 30 min. We used 100 mM of 6Ј-deoxyluciferin (luciferin-H) as a substrate for CYP2C9 and 20 mg human liver microsomes. CYP2C9 converts 6Ј-deoxyluciferin (luciferin-H) to luciferin (LUC) and the production of luciferin by CYP2C9 was determined using luciferase assays. Luminescence was measured using FLUOstar Optima (Moritex, Tokyo, Japan).
Duplicate determinations of CYP isoforms were performed.
Measurement of Flavonoids and Furanocoumarins in Citrus Extracts
For measurement of flavonoids, 100-300 mg of each citrus extract was refluxed 3 times with 50 ml methanol for 30 min at 80°C. The samples were concentrated under vacuum and dissolved in 200 ml methanol. Each sample was filtered through a 0.45 mm membrane filter (GL Science), and 5-10 ml was injected into the HPLC. Chromatography was conducted using a TSK gel ODS-120T column (4.6ϫ250 mm, 4 mm) (TOSOH, Tokyo, Japan). The column temperature was set at 40°C, and a UV-detector was set at 280 nm. The mobile phase consisted of 0.1% H 3 PO 4 : CH 3 CN (9 : 1) (A) and 0.1% H 3 PO 4 : CH 3 CN (2 : 8) (B). The mobile phase program consisted of three periods; 100% A (0 to 25 min), 70% A (25 to 35 min) and 100% B (35 to 45 min). Flow rate was maintained at 0.8 ml/min.
For measurement of bergapten, 300 ml of each 1 mg/ml citrus extract was mixed with 4 ml ethylacetate and 100 ml of 926 Vol. 31, No. 5 3 mM testosterone, as an internal standard. After stirring for 2 min, samples were centrifuged at 500ϫg for 15 min. The supernatant was evaporated to dryness and stored at Ϫ20°C until HPLC analysis. Residues were dissolved in 200 ml of 55% (v/v) methanol for HPLC. Chromatography was conducted using an Inertsil ODS-3 column (4.6ϫ250 mm, 5 mm) (GL Sciences). The column temperature was set at 40°C, and UV-detection at 254 nm. The mobile phase consisted of 55% methanol. Flow rate was maintained at 1.2 ml/min. For measurement of 6Ј,7Ј-DHB, 300 ml of each 1 mg/ml citrus extract was mixed with 4 ml ethylacetate and 100 ml 50 mM anthracene, as an internal standard. After stirring for 2 min, samples were centrifuged at 500ϫg for 15 min. The supernatant was evaporated to dryness and stored at Ϫ20°C until HPLC analysis. Residues were dissolved in 100 ml of acetonitrile for HPLC.
For measurement of bergamottin, 300 ml of each 10 mg/ml citrus extract was mixed with 4 ml ethylacetate and 100 ml of 50 mM anthracene, as an internal standard. After stirring for 2 min, samples were centrifuged at 500ϫg for 15 min. The supernatants were evaporated to dryness and stored at Ϫ20°C until HPLC analysis. Residues were dissolved in 100 ml acetonitrile for HPLC.
For both 6Ј,7Ј-DHB and bergamottin chromatography was conducted using an Inertsil ODS-3 column (4.6ϫ150 mm, 5 mm) (GL Sciences). The column temperature was set at 40°C, and the UV-detector was set at 310 nm. The mobile phase consisted of 75% methanol. Flow rate was maintained at 1.0 ml/min.
The amount of each component was determined from a standard curve prepared using the same procedures. For naringin and neohesperidin, the calibration curve was linear, in the range of 3.125 to 200 mg/ml. For hesperidin and narirutin, the calibration curve was linear, in the range 6.25 to 200 mg/ml.
Data Analysis All data are analyzed using the average of the duplicate determinations, and the 50% inhibitory concentration (IC 50 ) values were calculated by fitting the following Hill equation to CYP inhibition data using a nonlinear regression (WinNonlin, Pharsight Co., Mountain View, CA, U.S.A.): (1) where A is the observed remaining CYP activity for control, C is the concentration of citrus extracts, IC 50 is the concentration of citrus extracts at which 50% inhibition of CYP activity is observed, and g is the Hill coefficient.
The correlations among IC 50 values of citrus extracts for 3 CYP were evaluated using the Spearman correlations (Statview, SAS Institute, Cary, NC, U.S.A.). Figure 1 shows the inhibitory effects of extracts from im- mature citrus fruits on the activities of MD1H (CYP3A4), DMOD (CYP2D6) and LUC (CYP2C9). Inhibitory effects were evaluated by measuring the suppression of metabolite formation from the specific substrate for each CYP isoform. All examined citrus extracts inhibited the activities of CYP isoforms in a concentration-dependent manner. The IC 50 values calculated using Eq. 1 are shown in Table 1 in decreasing order of CYP3A4 IC 50 as well as the yield (%) of extract for each citrus fruit. The yield (%) of all citrus extracts examined ranged from 14 to 25%. Some citrus extracts showed particularly high inhibitory effects on MD1H and LUC activities; of these, C. paradisi (grapefruit) showed the highest inhibitory effects on MD1H activities as determined by the IC 50 value. C. iyo exhibited the greatest inhibitory effect on DMOD, and C. grandis and C. aurantiun var. daidai on LUC. The lowest inhibitory effects on CYP activities among the extracts tested were observed for C. unshiu. The IC 50 value of C. unshiu for CYP3A4 was about 15 times higher compared to that of C. paradisi. To understand the actual inhibitory effect as fruit, the IC 50 values were converted to equivalent mg dried fruit by using the yields shown in Table  1 . Table 2 shows the IC 50 (mg dried fruits/ml) estimated from yield (%) shown in Table 1 . Based on IC 50 values (mg dried fruits/ml), C. limon showed the highest inhibitory effects on MD1H activities. C. iyo exhibited the greatest inhibitory effect on DMOD, and C. aurantiun var. daidai on LUC.
RESULTS
To clarify the relationships among the inhibitory effects of each citrus extract on CYP, we carried out correlation analysis among the IC 50 values for the three CYP isoforms. The results are shown in Fig. 2 . Interestingly, the inhibition of MD1H (CYP3A4) activity was strongly correlated with inhibition of LUC (CYP2C9) activity (rϭ0.9444), although the latter was determined by bioluminescemce assay. No correlations were found among inhibitory effects on other CYP isoforms.
To elucidate the differences in IC 50 values among the extracts, we determined the amounts of certain flavonoids and 928 Vol. 31, No. 5 There was a significant correlation between CYP2C9 and CYP3A4 (pϽ0.0001).
furanocoumarins in the extracts. The results are shown in their order of IC 50 values for CYP3A4 (Table 3) . With respect to flavonoids, the extracts containing narirutin usually also contained hesperidin. The distribution of naringin and neohesperidin was generally similar among the extracts. Compared to flavonoids, lower amounts of furanocoumarins were observed in each citrus extract, although almost all extracts contained bergapten. The extracts containing naringin usually also contained bergamottin and 6Ј,7Ј-DHB. Citrus extracts containing relatively large amounts of naringin, 6Ј,7Ј-DHB and bergamottin exhibited higher inhibitory effects on MD1H activity. In contrast, citrus extracts containing narirutin and hesperidin without naringin have generally weak inhibitory effects on CYP3A4 activity.
DISCUSSION
Our study had two major findings. First, information on the inhibitory effects of extracts from immature fruits of 12 citrus cultivars on CYP activity was obtained. Second, extracts containing larger amounts of naringin, 6Ј,7Ј-DHB and bergamottin showed relatively strong inhibitory effects on CYP activities.
C. paradisi shows the most marked inhibition for CYP3A4, CYP2D6 and CYP2C9 within the 12 citrus extracts examined. The extracts, including C. paradisi, with lower IC 50 values for CYP3A4 contained high proportions of naringin, 6Ј,7Ј-DHB and bergamottin compared to the other citrus extracts, suggesting that these components could be an important factor in the inhibition of CYP3A4 activities. Inhibitory effects on CYP3A4 activities increased as the amounts of naringin and bergamottin increased. Nevertheless, inhibition by flavonoids is equivocal; naringin, for example, has been shown to cause marked inhibition 3) or no inhibition 4) of nifedipine metabolism. In vivo, it has been reported that naringin affected the pharmacokinetics of some drugs metabolized by CYP3A4. 13, 14) Other flavonoids in grapefruit juice inhibited activities of CYP1A2 and CYP2A6 in addition to CYP3A4. 15) Moreover, it has been reported that naringin and naringenin, the aglycone of naringin, are not the main components in grapefruit juice responsible for CYP3A4 inhibition [16] [17] [18] Naringin also inhibits the activity of transporters such as P-glycoprotein 19) or organic aniontransporting polypeptide 1A2 (OATP1A2). 20) Further studies are needed to clarify the effects of citrus extracts on transporter function. On the other hand, it has been reported that furanocoumarins function as major CYP3A4 inhibitors. The activities of CYP isoforms 1A2, 2A6, 2C9, 2C19, 2D6 and 2E1 in human liver microsomes were found to be inhibited by furanocoumarins.
21) The involvement of furanocoumarin in CYP inhibition was directly indicated by using a furanocoumarin-free grapefruit juice. 22) Alternatively, it has been reported that some furanocoumarins induced CYP activity in experimental animals and humans. [23] [24] [25] [26] [27] Other components in these citrus extracts, such as furanocoumarin dimers, may be involved in their inhibitory effects. It has been reported that furanocoumarin dimers, possibly derived from the geranyloxy monomer (6Ј,7Ј-DHB), function as potent and selective inhibitors of CYP3A4. 8, 9, 28, 29) Inhibitory effects for the relative yield of each fruit is also interesting to clarify the practical influence of citrus fruits on CYP activity, although the immature fruits were used in this study. In Table 2 , evaluated IC 50 (mg fruits/ml) for CYP showed the relatively strong inhibitory effects of C. paradisi. C. unshiu and C. sulcata exhibited relatively weak inhibition of CYP activities as well as the higher IC 50 value for extract weight, suggesting that the frequencies of drug interaction mediated by CYP inhibition could be low compared to other citrus fruits. IC 50 (mg fruits/ml) exhibited a similar trend to IC 50 (mg/ml) for each citrus extract.
Interestingly, our data showed that there was a positive correlation between the inhibition of CYP2C9 activity and inhibition of CYP3A4 by citrus extracts, although the inhibitory assays for CYP3A4 and CYP2C9 were performed by the different methods, that is, HPLC and bioluminescence methods. We cannot explain the exact mechanisms underlying the inhibition to both CYP3A4 and CYP2C9 as our experiments showed only the degree of inhibition by each citrus extract. The positive correlation between inhibition of CYP2C9 and that of CYP3A4 by citrus extracts could reflect a similar inhibitory mechanism. It is also possible that an interaction between substrates for CYP2C9 and CYP3A4 and citrus extracts occurs. In the case of irreversible inhibition; mechanism-based inhibition, the inactivator first binds to and is then catalytically activated by a target enzyme to a reactive intermediate that covalently binds to heme and/or protein in the enzyme active site, resulting in an irreversible loss of enzymatic activity. However, a similar competitive mechanism could be involved in the inhibition of CYP2C9 and CYP3A4 because this study, the correlation was derived from a simple reversible inhibition study. The correlation in inhibition between CYP3A4 and CYP2C9 and the precise mechanisms underlying this correlation need to be examined in detail using other specific substrates for each isoform and/or recombinant CYP isoforms.
Experiments on CYP activities via mechanism-based inhibition such as furafylline, 12) 8-methoxypsoralen 30, 31) and naturally occurring coumarins 32) indicate that loss of catalytic activities may be caused by denaturation of the apoprotein, modification of the heme group, or covalent binding of the inactivator to the active site of the enzyme. Tassaneeyakul et al. have reported that CYP-inhibition by furanocoumarins in grapefruit juice depends upon the preincubation period.
9) The same authors have suggested that inhibition by flavonoids and furanocoumarins was irreversible and resulted from a catalytic process. We did not investigate the mechanisms of inhibition of furanocoumarin components of grapefruit juice on CYP isoforms in the present study. However, furanocoumarins have previously been reported as mechanismbased inhibitors of CYP1A1 32) and CYP2A6. 31, 33) It is unclear whether flavonoids and furanocoumarins are involved in CYP2C9 inhibition via mechanism-based processes. Silybin, a major flavonoid constituent of milk thistle extract, is a mechanism-based inactivator of both CYP3A4 and CYP2C9 and this interaction can lead to irreversible enzyme degradation. 32) Further studies are needed to clarify the precise mechanisms of CYP inhibition, including mechanism-based processes.
In this study, we used immature fruits harvested in August. The amounts of flavonoids and furanocoumarins in citrus extracts vary according to the genetic background, the processing method and maturity. 5, [34] [35] [36] For example, the amounts of flavonoids in citrus extracts derived from immature fruits are higher compared to those from mature fruits. Thus, the antiallergic effect of hesperidin weakens with the maturity of the fruit. Recently, citrus fruit-drug interactions have been widely reported. Furanocoumarins such as bergapten and bergamottin in grapefruit juice are potent inhibitors of CYP3A4 activity. [2] [3] [4] Thus, the drug interaction induced by an extract from immature C. unshiu fruit might be expected to be less than that of other citrus extracts probably due to the lower levels of furanocoumarin in C. unshiu. This was reflected by the greater IC 50 value for CYP activities. In addition, the antiallergic effect of C. unshiu is higher compared to those of other citrus extracts. 37, 38) The results of this study suggest that C. unshiu has an antiallergic effect, but shows the relatively low frequency of drug interaction. C. paradisi (grapefruit) showed strong CYP inhibition, consistent with previous reports on C. paradisi and grapefruit juice. [39] [40] [41] [42] [43] [44] [45] Grapefruit juice enhances the bioavailability or systemic exposure of numerous CYP3A4 substrates by inhibiting intestinal first-pass metabolism. For the other citrus extracts examined, further studies should investigate the inhibitory effects on substrate metabolism, as shown by the CYP inhibition patterns of each citrus extract.
In conclusion, our present results showed that all citrus extracts examined inhibited CYP activities in a dose-dependent manner. Citrus extracts having lower IC 50 values such as C. paradisi contained naringin and furanocoumarins in abundance. These findings may help elucidate the roles of flavonoids and furanocoumarins in CYP inhibition, and suggest that citrus extracts containing high levels of narirutin and hesperidin and lower levels of furanocoumarins such as C. unshiu are favorable as antiallergic functional ingredients.
